US equities |
SPCX $167.12 ▲+5.13% NVDA $237.12 ▲+1.35% MU $1,064.79 ▼-0.94% TSLA $378.45 ▲+2.12% MSFT $525.24 ▲+1.49% INTC $116.30 ▼-2.54% SNDK $1,713.24 ▼-0.39% META $745.22 ▲+2.35%
FinancialContent

Alpha Cognition Inc. - Common Stock (NQ:ACOG)

9.050 -0.050 (-0.55%)
Delayed Quote Updated: 11:11 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpha Cognition Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences
From Alpha Cognition Inc.
Via Business Wire
News headline image
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗
This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study
From Alpha Cognition Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
Via TheNewswire.com
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution
From Alpha Cognition, Inc.
Via Business Wire
News headline image
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners
From Alpha Cognition Inc.
Via Business Wire
News headline image
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025
Dallas, Texas--(Newsfile Corp. - November 14, 2025) - Alpha... 
Via Newsfile
News headline image
Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q3 2025 Revenue Beat and Strong Commercial Progress for ZUNVEYL ↗
Alpha Cognition's Q3 2025 results beat revenue estimates by 37% on strong sales of its Alzheimer's drug, ZUNVEYL, showing significant commercial momentum. 
Via Chartmill
News headline image
Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Alpha Cognition to Present Clinical Data at Consultant Pharmacy and Neuroscience Education Institute Meetings
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Present Clinical Data at ASCP Annual Meeting
From Alpha Cognition Inc.
Via Business Wire
BioMedNewsBreaks — Alpha Cognition Inc. (NASDAQ: ACOG) Prices $35 Million Oversubscribed Public Offering
Via Investor Brand Network
News headline image
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
From Alpha Cognition Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Alpha Cognition Inc. Announces Proposed Public Offering of Common Shares
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Inc. (Nasdaq: ACOG) Announces Participation in Key September Investor Conferences
From Alpha Cognition Inc.
Via Business Wire
News headline image
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q2 2025
Dallas, Texas--(Newsfile Corp. - August 15, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate... 
Via Newsfile
News headline image
Alpha Cognition Inc. Reports Second Quarter 2025 Financial Results and Provides Operational Update
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Study Data at Alzheimer’s Association International Conference
From Alpha Cognition Inc.
Via Business Wire
News headline image
Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
From Alpha Cognition Inc.
Via Business Wire
News headline image
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025
Dallas, Texas--(Newsfile Corp. - May 19, 2025) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate... 
Via Newsfile
Topics Intellectual Property
News headline image
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview
From Alpha Cognition Inc.
Via Business Wire
< Previous 1 2 3 Next >